[Hepatitis B viral mutation and its clinical significance].
Asahina
Yasuhiro
Y
Division of Gastroenterology and Hepatology, Musashino Red Cross Hospital.
Izumi
Namiki
N
D000998:Antiviral Agents / Q000627:therapeutic use; D005838:Genotype; D006509:Hepatitis B / Q000188:drug therapy / Q000503:physiopathology / Q000821:virology*; D006512:Hepatitis B Core Antigens / Q000235:genetics; D006514:Hepatitis B Surface Antigens / Q000235:genetics; D006513:Hepatitis B e Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000235:genetics*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D009154:Mutation; D016133:Polymerase Chain Reaction; D016896:Treatment Outcome
D000998:Antiviral Agents; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D019259:Lamivudine